Showing results (411-420 of 2,398) with videos related to

Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|January 3, 2022
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstructionPeng Gao, Xiangyu Wang, Ping Bai, et al.
Breast Cancer (Tokyo, Japan)|December 5, 2021
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3Barbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Breast Cancer (Tokyo, Japan)|September 29, 2022
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapyShozo Ohsumi, Reiki Nishimura, Norikazu Masuda, et al.
Breast Cancer (Tokyo, Japan)|October 15, 2018
Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patientsEiji Suzuki, Masahiro Sugimoto, Kosuke Kawaguchi, et al.
Breast Cancer (Tokyo, Japan)|February 7, 2022
The collagenase of the bacterium Clostridium histolyticum does not favor metastasis of breast cancerYannick Fabian Diehm, Katharina Marstaller, Anna-Maria Seckler, et al.
Breast Cancer (Tokyo, Japan)|March 18, 2022
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 monthsKen Yoshida, Takayuki Nose, Yuki Otani, et al.
Breast Cancer (Tokyo, Japan)|April 6, 2022
BAP1-defficient breast cancer in a patient with BAP1 cancer syndromeAna Blatnik, Domen Ribnikar, Vita Šetrajčič Dragoš, et al.
Breast Cancer (Tokyo, Japan)|March 22, 2022
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer RegistryMitsuo Terada, Minoru Miyashita, Hiraku Kumamaru, et al.
Breast Cancer (Tokyo, Japan)|April 18, 2022
Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trialHitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, et al.
Breast Cancer (Tokyo, Japan)|September 27, 2018
p21Waf1/Cip1: its paradoxical effect in the regulation of breast cancerSamir F Zohny, Abdulrahman L Al-Malki, Mazin A Zamzami, et al.
Pageof 240